U
NURO

UBS’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

UBS’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6K Buy
+1
New +$4.66K ﹤0.01% 9322
2014
Q2 		– Hold
0
– – – 10084
2014
Q1 		– Sell
-1
Closed -$7K – 10911
2013
Q4 		$7K Buy
+1
New +$5.62K ﹤0.01% 9350
2013
Q3 		– Sell
-1
Closed -$4.42K – 9996
2013
Q2 		$3K Buy
+1
New +$5.3K ﹤0.01% 9649

Other funds holding NURO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS's NURO Position: Q3 2014 in Review

UBS opened a new position in NeuroMetrix, Inc. Common Stock (NURO) in Q3 2014: 1 share worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #9322 among its holdings. This is a return to the name: UBS previously reported a position in NURO as recently as Q4 2013.

UBS first reported a position in NURO in Q2 2013 and has held it in 3 quarters since. The position peaked at $7K in Q4 2013. 8 funds tracked by Wall St. Rank hold NURO as of Q3 2014.

  • UBS held 1 share of NeuroMetrix, Inc. Common Stock worth $6K as of Q3 2014.
  • NeuroMetrix, Inc. Common Stock was a new UBS position in Q3 2014.
  • NeuroMetrix, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9322 holding.
  • UBS first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2013 and has held it in 3 quarters since.
  • UBS's NeuroMetrix, Inc. Common Stock position peaked at $7K in Q4 2013.
  • 8 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.